Shasqi
Shasqi is a clinical-stage biotechnology company advancing cancer treatment through click chemistry. Its CAPAC (Click Activated Protodrugs Against Cancer) platform uses a pre-targeting approach that captures therapeutic payloads at the tumor via in-vivo click chemistry, separating tumor-targeting molecules from their drug payloads and reuniting them at the cancer site to maximize drug delivery while reducing systemic toxicity. The company builds on the 2022 Nobel Prize-winning click chemistry work and operates as a therapeutics developer rather than a technology or API platform. Added to the API Evangelist network as a Y Combinator portfolio company; enrichment found no public developer API, SDK, or technical platform surface.
Shasqi is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Cancer Therapeutics.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API